BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Hong Y, Xi HT, Yang XY, Su WW, Li XP. Pathogenic genes and clinical prognosis in hypertrophic cardiomyopathy. World J Cardiol 2025; 17(1): 99595 [PMID: 39866219 DOI: 10.4330/wjc.v17.i1.99595]
URL: https://www.wjgnet.com/1949-8462/full/v17/i1/99595.htm
Number Citing Articles
1
Hui Chen, Li-Li Jiang, Chun-Mei Luo, Tian-Yu Chen, Chang-Han Ouyang. Network pharmacology research and experimental verification of dietary flavonoid fisetin in treating myocardial hypertrophyJournal of Asian Natural Products Research 2026; 28(3): 491 doi: 10.1080/10286020.2025.2526826
2
Yuntao Liang, Abdallah Iddy Chaurembo, Francis Chanda, Baraka Simon Mayaba, Mi Tian, Zi-feng Huang, Na Xing, Han-bin Lin. Proteomic research in clinical samples of cardiovascular diseasesMedicine in Drug Discovery 2026; 30: 100253 doi: 10.1016/j.medidd.2026.100253
3
Arnold Kukowka, Marek Droździk. Cardiac Myosin Inhibitors in the Treatment of Hypertrophic Cardiomyopathy: Clinical Trials and Future ChallengesBiomolecules 2025; 15(8): 1098 doi: 10.3390/biom15081098
4
Jing Zhang, Kai Li, Huan Min, Yang Xie, Chunmei Zhou, Bo Shi. Three-Dimensional Speckle Tracking Echocardiography for Assessing the Degree of Myocardial Fibrosis and Predicting Prognosis in Patients With Hypertrophic CardiomyopathyKardiologiia 2026; 66(3): 74 doi: 10.18087/cardio.2026.3.n3064
Write to the Help Desk